Drug Type Gene editing |
Synonyms ABO 101 (Arbor Biotechnologies), ABO101 (Arbor Biotechnologies) |
Target |
Mechanism GOX inhibitors(Hydroxyacid oxidase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Primary Hyperoxaluria Type 1 | Preclinical | US | Arbor Biotechnologies, Inc.Startup | 09 May 2024 |